First-lineAdenocor

Adenosine

Purinergic A1 receptor agonist / AV nodal blocker

First-line for stable maternal SVT — safe every trimester.

IV rapid push

First-line for

  • Stable narrow-complex SVT in pregnancy
  • Diagnostic unmasking of AF/flutter

Mechanism

Transient A1 activation hyperpolarises AV node → block re-entrant SVT circuits; half-life <10 s.

"6-12-12, flush fast"

  • 6 mg → 12 mg → 12 mg via large-bore proximal cannula
  • Warn patient of chest tightness, doom feeling
  • Halve dose on dipyridamole or heart transplant

Dosing

First dose
6 mg IV rapid push + 20 mL saline flush
Second/third
12 mg if no response

Contraindications

  • Absolute2°/3° AV block without pacemaker
  • AbsoluteSevere asthma (bronchospasm)
  • AbsoluteLong QT / decompensated HF

Side effects

  • Chest tightness, flushing, dyspnoea (seconds)
  • Transient asystole
  • Bronchospasm (asthma)
  • Sinus pause

Fetal & maternal notes

  • Half-life <10 s → negligible placental transfer
  • Safe every trimester

Key interactions

  • Dipyridamole

    Avoid

    Potentiates — halve dose

  • Theophylline / caffeine

    Caution

    Antagonise — may need higher dose

Clinical pearls

  • 💡 Do vagal manoeuvres first (Valsalva, modified REVERT)
  • 💡 Have defibrillator and airway ready

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.